Economy
Agreement Inked To Establish Vaccines Factory In Khazaen City Worth RO20M
Khazaen Economic City signed an agreement with Opal For Biopharmaceuticals and Business Company to establish a factory for the production of biological human vaccines to the tune of RO20mn.
The first phase of the project will be set up on a total area of 37,000 square meters.

The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal For Biopharmaceuticals and Business Company.
Al Thuhli said that this project will be the first vaccines factory in Khazaen Economic City and it targets local and international markets. The agreement, Al Thuhli added, comes as part of Khazaen’s efforts in attracting local and international investments.
-
Dossier2 months agoDossier Construction Awards 2025 Celebrates Pioneers in Construction, Infrastructure and Real Estate
-
Arts and Culture2 months agoROHM To Premiere Arabic-Language Grand Opera – ‘Sindbad: The Omani Sailor,’ on Oct 3 and 5
-
News3 weeks agoKitchenomiKs Secures Investment of US$3.2M Led by Jasoor Ventures
-
Magazines4 weeks agoOER – September 2025 Issue
-
Insurance2 months agoLiva Insurance Sweeps Three Major Wins at Alam Al-Iktisaad Awards 2025
-
News4 weeks agoCent Capital, AI Finance App by ex-AWS Strategist ‘The Beast of Bay Area,’ Launches to End Financial Anxiety, Hits $1M AUM
-
News3 weeks agoIEA Expects Global Oil Market to Remain Oversupplied in 2026
-
News4 weeks agoOman Inaugurates ‘Hadatha’ – Its All-New Cybersecurity Center
